ChromoGenics AB
Symbol: CHRO.ST
STO
7
SEKMarknadspris idag
-0.4925
P/E-tal
0.0000
PEG-kvot
28.87M
MRK Aktiekapital
- 0.00%
DIV Avkastning
{{företagets_namn}} (CHRO-ST) Finansiella rapporter
Balansräkning
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.9 | 24.1 | 18.9 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 0 | 11.7 | 11.7 | 13.7 | ||||||||||
balance-sheet.row.inventory | 0 | 10.2 | 10.2 | 11 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 9 | 0.1 | 2.2 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 29.8 | 46 | 45.7 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 98.3 | 103 | 101.8 | ||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0.6 | 1.5 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 10.7 | 11.7 | 9 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 10.7 | 12.3 | 10.5 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0.4 | 0.4 | 0 | ||||||||||
balance-sheet.row.tax-assets | 0 | -0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.4 | -0.3 | 2.5 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 109.4 | 115.5 | 114.8 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 139.2 | 161.5 | 160.4 | ||||||||||
balance-sheet.row.account-payables | 0 | 2.8 | 8.6 | 7.8 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 0.2 | 0.3 | 15.4 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 66.6 | 63.8 | 46.3 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 24.4 | 15.9 | 3.4 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 66.6 | 66.2 | 50.1 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-liab | 0 | 94 | 91 | 102.7 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 35.1 | 28.7 | 3.4 | ||||||||||
balance-sheet.row.retained-earnings | 0 | -715.4 | -661.1 | -601.7 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 9.9 | 8.1 | 5.6 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 713.2 | 694.8 | 650.3 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 42.8 | 70.5 | 57.7 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 139.2 | 161.5 | 160.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 0 | 42.8 | 70.5 | 57.7 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 0.4 | 0.4 | 2.5 | ||||||||||
balance-sheet.row.total-debt | 0 | 66.8 | 64.1 | 61.7 | ||||||||||
balance-sheet.row.net-debt | 0 | 58.9 | 40 | 42.8 |
Kassaflödesanalys
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -52.5 | -55.9 | -59.7 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 4.5 | 3.4 | 2.3 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 4.5 | -5.8 | 2.5 | ||||||||||
cash-flows.row.account-receivables | 0 | 0.1 | 6.1 | -3.8 | ||||||||||
cash-flows.row.inventory | 0 | 0 | 0.8 | -2.8 | ||||||||||
cash-flows.row.account-payables | 0 | -5.8 | 0.8 | -0.4 | ||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | -13.6 | 9.4 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | 2.7 | -0.9 | -3.9 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.3 | -0.1 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 24.8 | 69.8 | 0.3 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 69.5 | 0.2 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 24.8 | 69.5 | 0.2 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | -16.2 | 5.3 | -74.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.9 | 24.1 | 18.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 24.1 | 18.9 | 93.4 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | -40.8 | -59.3 | -58.8 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.free-cash-flow | 0 | -41 | -64.2 | -74.7 |
Resultaträkning rad
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 13.6 | 18.3 | 24.7 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 64.3 | 15 | 15.9 | ||||||||||
income-statement-row.row.gross-profit | 0 | -50.6 | 3.3 | 8.7 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 29 | 25.1 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 55.8 | 60.8 | 69.6 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 64.3 | 75.8 | 85.6 | ||||||||||
income-statement-row.row.interest-income | 0 | 0.5 | 0.6 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 0 | 4.3 | 1.7 | 4 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.9 | 0.6 | -2.7 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 29 | 25.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.9 | 0.6 | -2.7 | ||||||||||
income-statement-row.row.interest-expense | 0 | 4.3 | 1.7 | 4 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 4.5 | 5 | 3.4 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | -50.6 | -57.5 | -60.9 | ||||||||||
income-statement-row.row.income-before-tax | 0 | -52.5 | -57 | -63.5 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | -0.6 | 3.8 | ||||||||||
income-statement-row.row.net-income | 0 | -52.5 | -56.4 | -67.3 |
Ofta ställda frågor
Vad är ChromoGenics AB (CHRO.ST) totala tillgångar?
ChromoGenics AB (CHRO.ST) totala tillgångar är 139163000.000.
Vad är företagets årliga omsättning?
Den årliga intäkten är N/A.
Vad är företagets vinstmarginal?
Företagets vinstmarginal är -0.745.
Vad är företagets fria kassaflöde?
Fritt kassaflöde är -10.337.
Vad är företagets nettovinstmarginal?
Nettovinstmarginalen är -3.912.
Vad är företagets totala intäkter?
Totala intäkter är -3.675.
Vad är ChromoGenics AB (CHRO.ST) nettovinst (nettoinkomst)?
Nettovinst (nettoinkomst) är -52506000.000.
Vad är företagets totala skuldsättning?
Den totala skulden är 66819999.000.
Vad är rörelsens kostnader?
Rörelsens kostnader är 55824000.000.
Vad är företagets kassaflöde?
Företagets kassa är 0.000.